Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Combined Pulsed Field and Radiofrequency Energy for Ablation of Ventricular Tachycardia

NCT: NCT06816368 · ACTIVE_NOT_RECRUITING

NCT IDNCT06816368
StatusACTIVE_NOT_RECRUITING
Start Date2025-07-28
Completion2026-08

Brief Summary

This will be a single arm study evaluating a new ablation technology for performing catheter ablation of ventricular tachycardia. The technology combines novel pulsed field ablation with radiofrequency ablation.

Frequently Asked Questions

What is Combined Pulsed Field and Radiofrequency Energy for Ablation of Ventricular Tachycardia?

Combined Pulsed Field and Radiofrequency Energy for Ablation of Ventricular Tachycardia is a clinical trial registered under NCT06816368. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06816368?

The current status of NCT06816368 (Combined Pulsed Field and Radiofrequency Energy for Ablation of Ventricular Tachycardia) is: ACTIVE_NOT_RECRUITING.

When did Combined Pulsed Field and Radiofrequency Energy for Ablation of Ventricular Tachycardia start?

Combined Pulsed Field and Radiofrequency Energy for Ablation of Ventricular Tachycardia started on 2025-07-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑